Exchange: NASDAQ·Updated 07:30 PM EDT

INTS INTENSITY THERAPEUTICS, INC.

$3.63
$0.05
(1.36%)
Today
Closed $3.63
$0.00
(0.00%)
After Hours
Reported EarningsAug 11
Mkt Cap$11.85M
Vol16,725.00

About INTS

Intensity Therapeutics, Inc. is a clinical-stage biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.
50

Neutral Sentiment

How do you feel about INTS?

TNNSTrade
$INTS don't worry about the daily action here. Once the delivery system and technology are validated, this will be worth a lot more. We have the right mission and outcomes to do great things for the world.
1
Atrain1189
$INTS if I remember correctly, there was a private buyer in this at 80 cents pre split. Which would mean $20 is their average cost if they haven’t sold or averaged down
1
joel12365
$INTS recent drop due to q3 being nearly over both data sets not published yet and sarcoma hasnt been mentioned.. we will see
ReetzVirtu
$INTS This is "building momentum"? lol. all joking aside, I agree with the first half of your statement.

Advertisement|Remove ads.